Search

Your search keyword '"Harvey I. Pass"' showing total 626 results

Search Constraints

Start Over You searched for: Author "Harvey I. Pass" Remove constraint Author: "Harvey I. Pass" Language undetermined Remove constraint Language: undetermined
626 results on '"Harvey I. Pass"'

Search Results

4. Supplemental Table S4 from Metabolomic Markers of Altered Nucleotide Metabolism in Early Stage Adenocarcinoma

5. Table S6 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

6. Table S7 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

7. Supplemental Material from Metabolomic Markers of Altered Nucleotide Metabolism in Early Stage Adenocarcinoma

8. Supplementary Figure All from Lower Airway Dysbiosis Affects Lung Cancer Progression

9. Data from Lower Airway Dysbiosis Affects Lung Cancer Progression

10. Data from Metabolomic Markers of Altered Nucleotide Metabolism in Early Stage Adenocarcinoma

11. Table S1 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

12. Supplementary File Table All (excel) from Lower Airway Dysbiosis Affects Lung Cancer Progression

13. Data from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

14. Table S3 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

15. Table S5 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

16. Table S2 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

17. Figure S1 from Metabolomic Markers of Altered Nucleotide Metabolism in Early Stage Adenocarcinoma

18. Supplementary Data from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

19. Supplementary Table from Lower Airway Dysbiosis Affects Lung Cancer Progression

20. Table S4 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

22. Supplementary Figure 2 from Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma

23. Data from A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non–Small Cell Lung Cancer and Serum DNA

24. Supplementary Figure 4 from HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients

25. Data from Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma

26. Supplementary Table S1 from A Panel of Novel Detection and Prognostic Methylated DNA Markers in Primary Non–Small Cell Lung Cancer and Serum DNA

29. Supplementary Figure 3 from Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma

39. Supplementary Figure 7 from Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma

44. Data from CSPG4 as a Target of Antibody-Based Immunotherapy for Malignant Mesothelioma

45. Supplementary Figure 5 from Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma

46. Supplementary Figure 4 from Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma

47. Supplementary Video 2 from Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma

49. Supplementary Figure 1 from HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients

50. Supplementary Figure 6 from Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma

Catalog

Books, media, physical & digital resources